All In Biotech

Drug Trial Radar · NCT07798609

A Trial to Assess Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of SFL-0821 in Adults With FSHD

A Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Trial to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of SFL-0821 in Adults With Facioscapulohumeral Muscular Dystrophy (FSHD)

Last checked: Nov 19, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

90

Planned (sponsor's estimate)

Start

Oct 14, 2026

Primary completion

Aug 2029

Study completion Aug 2029

Sponsor

Lead sponsor
Soufflé Therapeutics, Inc.Industry
Sponsor type
Industry
First posted
Sep 1, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Randomized
Model
Sequential
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the safety, tolerability, and preliminary efficacy of SFL-0821 in adult patients with Facioscapulohumeral Muscular Dystrophy (FSHD)

Conditions

  • Facioscapulohumeral Muscular Dystrophy (FSHD)

Interventions

  • SFL-0821 for injectionDrug

    single or multiple doses of SFL-0821 by intravenous (IV) infusion

  • PlaceboDrug

    calculated volume to match active treatment by IV infusion

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of participants with treatment-emergent adverse events, serious adverse events, and any other dose-limiting toxicities as assessed by CTCAE v6.0.Time frame: Part A: Up to Week 24; Part B: Up to Week 48

Locations

6 sites in 2 countries. Site status is shown where the registry gives one.

  • Concord Repatriation General Hospital

    Concord, New South Wales, Australia · Not yet recruiting

  • Liverpool Hospital

    Liverpool, New South Wales, Australia · Not yet recruiting

  • Wesley Research Institute

    Brisbane, Queensland, Australia · Not yet recruiting

  • Mater Hospital Brisbane

    South Brisbane, Queensland, Australia · Recruiting

  • The Alfred Hospital

    Melbourne, Victoria, Australia · Recruiting

  • Pacific Clinic Research Network

    Auckland, Auckland, New Zealand · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.